Related Experiment Video
Updated: Jul 3, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
1Department of Nuclear Medicine, PET Center and Thyroid Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. luca.giovanella@eoc.ch
Clinical Chemistry and Laboratory Medicine
|July 9, 2008
Summary
Highly sensitive thyroglobulin assays simplify differentiated thyroid cancer follow-up. Undetectable levels during treatment can forgo stimulation, while rising levels reliably detect recurrence, reducing patient burden.
Area of Science:
- Endocrinology
- Oncology
- Medical Diagnostics
Background:
- Differentiated thyroid cancer (DTC) has a good prognosis, with total thyroidectomy and iodine-131 ablation as initial treatment.
- Thyroglobulin (Tg) measurement is crucial for DTC follow-up, as thyroid cells are its sole source.
- Older Tg assays required thyrotropin stimulation to detect residual disease due to suboptimal sensitivity.
Purpose of the Study:
- To evaluate the impact of highly sensitive thyroglobulin assays on DTC follow-up protocols.
- To determine if thyrotropin stimulation is still necessary with modern, sensitive Tg assays.
- To assess the utility of sensitive Tg assays in detecting recurrent DTC.
Main Methods:
- Review of current literature and clinical practice guidelines regarding DTC follow-up.
- Analysis of the performance characteristics of modern, highly sensitive thyroglobulin assays.
- Comparison of outcomes with and without thyrotropin stimulation in DTC patients.
Main Results:
- Highly sensitive Tg assays can detect minimal residual disease even with suppressed thyrotropin levels.
- Undetectable Tg during levothyroxine therapy is often sufficient to forgo thyrotropin stimulation.
- Increasing Tg concentrations in sensitive assays are early indicators of DTC recurrence.
Conclusions:
- Modern sensitive Tg assays simplify DTC follow-up, potentially eliminating the need for thyrotropin stimulation in many cases.
- Sensitive Tg assays enable early detection of recurrent DTC, improving patient management.
- Optimized follow-up protocols using sensitive Tg assays can reduce patient burden and healthcare costs.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...